Oxidants, nitrosants, and the lung

American Journal of Medicine

Volumn 109, Issue 5, 2000, Pages 398-421

  Van Der Vliet, Albert ^a   Cross, Carroll E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HEME OXYGENASE; LYMPHOKINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN DERIVATIVE; NITROSANT; OXYGEN RADICAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIOXIDANT ACTIVITY; APOPTOSIS; ASTHMA; CELL ACTIVATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; GENE EXPRESSION; GENE THERAPY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG LAVAGE; OXIDATION; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT MUCOSA; SECOND MESSENGER; TISSUE CULTURE;

ANTIOXIDANTS; BRONCHOALVEOLAR LAVAGE FLUID; EPITHELIAL CELLS; HUMAN; IMMUNITY, CELLULAR; INFLAMMATION; LUNG; LUNG DISEASES; MUCUS; NITRIC OXIDE; OXIDANTS; SIGNAL TRANSDUCTION; STRESS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033804587     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00479-4     Document Type: Conference Paper

References (228)

1. Bals R, Weiner DJ, Wilson JM. The innate immune system in cystic fibrosis lung disease. J Clin Invest. 1999;103:303-307.
2. Carlsson LM, Jonsson J, Edlund T, Marklund SL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci USA. 1995;92:6264-6268.
3. Davis WB, Pacht ER. Extracellular antioxidant defenses. In: Crystal RG, West JB, Barnes PJ, eds. The Lung: Scientific Foundations. New York: Raven Press; 1997:2271-2278.
4. Folz RJ, Guan J, Seldin MF, et al. Mouse extracellular superoxide dismutase: primary structure, tissue-specific gene expression, chromosomal localization, and lung in situ hybridization. Am J Respir Cell Mol Biol. 1997;17:393-403.
5. Su WY, Folz R, Chen JS, et al. Extracellular superoxide dismutase mRNA expressions in the human lung by in situ hybridization. Am J Respir Cell Mol Biol. 1997;16:162-70.
6. Avissar N, Finkelstein JN, Horowitz S, et al. Extracellular glutathione peroxidase in human lung epithelial lining fluid and in lung cells. Am J Physiol. 1996;14:L173-L182.
7. Cantin AM, Fells GA, Hubbard RC, Crystal RG. Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract. J Clin Invest. 1990;86:962-971.
8. Cross CE, Halliwell B, Allen A. Antioxidant protection: a function of tracheobronchial and gastrointestinal mucus. Lancet. 1984;1: 1328-1330.
9. Hiraishi H, Terano A, Ota S, et al. Role for mucous glycoprotein in protecting cultured rat gastric mucosal cells against toxic oxygen metabolites. J Lab Clin Med. 1993;121:570-578.
10. Kaliner MA. Human nasal respiratory secretions and host defense. Am Rev Respir Dis. 1991;144:S52-S56.
11. Gum JR. Human mucin glycoproteins: varied structures predict diverse properties and specific functions. Biochem Soc Trans. 1995; 23:795-799.
12. Girod S, Zahm JM, Plotkowski C, et al. Role of the physicochemical properties of mucus in the protection of the respiratory epithelium. Eur Respir J. 1992;5:477-487.
13. Cooper B, Creeth JM, Donald AS. Studies of the limited degradation of mucus glycoproteins. The mechanism of the peroxide reaction. Biochem J. 1985;228:615-626.
14. Adler KB, Holdenstauffer WJ, Repine JE. Oxygen metabolites stimulate release of high-molecular-weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via an arachidonic acid-dependent mechanism. J Clin Invest. 1990;85: 75-85.
15. Hiraishi H, Terano A, Ota S, et al. Oxygen metabolites stimulate mucous glycoprotein secretion from cultured rat gastric mucus cells. Am J Physiol. 1991;261:G662-G668.
16. Takeyama K, Dabbagh K, Shim JJ, et al. Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol. 2000;164:1546-1552.
17. Kanofsky JR, Sima PD. Reactive absorption of ozone by aqueous biomolecule solutions - implications for the role of sulfhydryl compounds as targets for ozone. Arch Biochem Biophys. 1995;316: 52-62.
18. Langford SD, Bidani A, Postlethwait EM. Ozone-reactive absorption by pulmonary epithelial lining fluid constituents. Toxicol Appl Pharm. 1995;132:122-130.
19. Mustafa MG. Biochemical basis of ozone toxicity. Free Rad Biol Med. 1990;9:245-265.
20. Costing RS, Vangreevenbroek MMJ, Verhoef J, et al. Structural and functional changes of surfactant protein A induced by ozone. Am J Physiol. 1991;261:L77-L83.
21. Pryor WA. Mechanisms of radical formation from reactions of ozone with target molecules in the lung. Free Rad Biol Med. 1994; 17:451-465.
22. van der Vliet A, Cross CE, O'Neill CA, et al. Determination of low-molecular mass antioxidant concentrations in human respiratory tract lining fluids. Am J Physiol. 1999;276:L289-L296.
23. Cross CE, van der Vliet A, O'Neill CA, et al. Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect. 1994;102(suppl):185-191.
24. Hatch GE. Comparative biochemistry of the airway lining fluid. In: Parent RA, ed. Treatise on Pulmonary Toxicology. Vol 1. Boca Raton: CRC Press; 1992:617-632.
25. Yoneda K. Mucus blanket of rat bronchus: an ultrastructural study. Am Rev Respir Dis. 1976;114:837-842.
26. DiSilvestro RA, Pacht E, Davis WB, et al. BAL fluid contains detectable superoxide dismutase 1 activity. Chest. 1998;113:401-404.
27. Salathe M, Holderby M, Forteza R, et al. Isolation and characterization of a peroxidase from the airway. Am J Respir Cell Mol Biol. 1997;17:97-105.
28. Maples KR, Mason RP. Free radical metabolite of uric acid. J Biol Chem. 1988;263:1709-1712.
29. Packer JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature. 1979; 278:737-738.
30. Eiserich JP, van der Vliet A, Handelman GJ, et al. Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr. 1995;62(suppl 6):1490S-1500S.
31. Mudway IS, Blomberg A, Frew AJ, et al. Antioxidant consumption and repletion kinetics in nasal lavage fluid following exposure of healthy human volunteers to ozone. Eur Respir J. 1999;13:1429-1438.
32. Rüstow B, Haupt R, Stevens PA, Kunze D. Type-II pneumocytes secrete vitamin-E together with surfactant lipids. Am J Physiol. 1993;265:L133-L139.
33. Pacht ER, Kaseki H, Mohammed JR, et al. Deficiency of vitamin E in the alveolar fluid of cigarette smokers. J Clin Invest. 1986;77: 789-796.
34. Pryor WA. Can vitamin E protect humans against the pathological effects of ozone in smog. Am J Clin Nutr. 1991;53:702-722.
35. Wang X, Quinn PJ. Vitamin E and its function in membranes. Prog Lipid Res. 1999;38:309-336.
36. Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol. 1987;63:152-157.
37. Meyer A, Buhl R, Kampf S, Magnussen H. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med. 1995;152:1055-1060.
38. Pacht ER, Timerman AP, Lykens MG, Merola AJ. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest. 1991;100:1397-1403.
39. Boehme DS, Maples KR, Henderson RF. Glutathione release by pulmonary alveolar macrophages in response to particles in vitro. Toxicol Lett. 1992;60:53-60.
40. Gao L, Kim KJ, Yankaskas JR, Forman HJ. Abnormal glutathione transport in cystic fibrosis airway epithelia. Am J Physiol. 1999;277: L113-L118.
41. Lindsell P, Hanrahan JW. Glutathione permeability of CFTR. Am J Physiol. 1998;275:C323-C326.
42. Rodriguez-Aguilera JC, Navas P. Extracellular ascorbate stabilization: enzymatic or chemical process. J Bioenerg Biomemb. 1994;26:379-384.
43. Rumsey SC, Levine M. Absorption, transport, and disposition of ascorbic in humans. J Nutr Biochem. 1998;9:116-130.
44. Peden DB, Hohman R, Brown ME, et al. Uric acid is a major antioxidant in human nasal airway secretions. Proc Natl Acad Sci USA. 1990;87:7638-7642.
45. Peden DB, Swiersz M, Ohkubo K, et al. Nasal secretion of the ozone scavenger uric acid. Am Rev Respir Dis. 1993;148:455-461.
46. Terao J, Nagao A. Antioxidative effect of human saliva on lipid peroxidation. Agric Biol Chem. 1991;55:869-872.
47. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J. 1986;235:747-754.
48. Schallreuter KU, Wood JM. The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem Biophys Res Comm. 1986;136:630-637.
49. Presti D, Scott JE. Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH·) radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct. 1994;12:281-288.
50. 2+-mediated oxidation of liposomes. Febs Lett. 1996; 383:155-158.
51. DeLisser HM, Albelda SM. The function of cell adhesion molecules in lung inflammation. More questions than answers. Am J Respir Cell Mol Biol. 1998;19:533-536.
52. Sacca R, Cuff CA, Ruddle NH. Mediators of inflammation. Curr Opin Immunol. 1997;9:851-857.
53. 2-integrin CD6/CD18 activation. Eur J Immunol. 1999;29:3419-3431.
54. Hogg JC, Doerschuk CM. Leukocyte traffic in the lung. Ann Rev Physiol. 1995;57:97-114.
55. Toda K, Kayano K, Karimova A, et al. Antisense intracellular adhesion molecule-1 (ICAM-1) oligodeoxyribonucleotide delivered during organ preservation inhibits posttransplant ICAM-1 expression and reduces primary lung isograft failure. Circ Res. 2000; 86:166-174.
56. Babior BM. NADPH oxidase: an update. Blood. 1999;93:1464-1476.
57. Verhoeven AJ. The NADPH oxidase: lessons from chronic granulomatous disease neutrophils. Ann NY Acad Sci. 1997;832:85-92.
58. phox-/- mice. J Clin Invest. 1998;101:1843-1850.
59. Pollock JD, Williams DA, Gifford MAC, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nature Genetics. 1995;9:202-209.
60. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood. 1998;92:3007-3017.
61. Rosen H, Michel BR. Redundant contribution of myeloperoxidase-dependent systems to neutrophil-mediated killing of Escherichia coli. Infect Immun. 1997;65:4173-4178.
62. Lanza F. Clinical manifestation of myeloperoxidase deficiency. J Mol Med. 1998;76:676-681.
63. Aretani Y, Koyama H, Nyui S, et al. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun. 1999;67:1828-1836.
64. Tenovuo J, Måkinen KK. Concentration of thiocyanate and ionizable iodine in saliva of smokers and nonsmokers. J Dent Res. 1976;55:661-663.
65. Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest. 1997;99:2075-2081.
66. Wu W, Chen Y, Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem. 1999;274:25933-25944.
67. Reynolds WF, Chang E, Douer D, et al. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood. 1997;90:2730-2737.
68. Nagra RM, Becher B, Tourtellotte WW, et al. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol. 1997;78:97-107.
69. Cascorbi I, Henning S, Brockmüller J, et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -463A of the myeloperoxidase gene. Cancer Res. 2000;60:644-649.
70. London SJ, Lehman TA, Taylor JA. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res. 1997;47:5001-5003.
71. Wolin MS, Burke-Wolin TM, Mohazzab-H KM. Roles for NAD(P)H oxidases, and reactive oxygen species in vascular oxygen sensing mechanisms. Respir Physiol. 1999;115:229-238.
72. Lu H, Youker K, Ballantyne C, et al. Hydrogen peroxide induces LFA-1-dependent neutrophil adherence to cardiac myocytes. Am J Physiol. 2000;278:H835-H842.
73. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med. 1994;149: 538-551.
74. De Sanctis GT, MacLean JA, et al. Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med. 1999;189:1621-30.
75. Scott JA, Craig I, McCormack DG. Nonadrenergic noncholinergic relaxation of human pulmonary arteries is partially mediated by nitric oxide. Am J Respir Crit Care Med. 1996;154:629-32.
76. Horvàth I, Donnelly LE, Kiss A, et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med. 1998;158:1042-1046.
77. Guo FH, Deraeve HR, Rice TW, et al. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA. 1995;92:7809-7813.
78. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest. 1997;10:2417-2423.
79. Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 1998;41:1141-1151.
80. Eiserich JP, Butler J, van der Vliet A, et al. Nitric oxide rapidly scavenges tyrosine and tryptophan radicals. Biochem J. 1995;310: 745-749.
81. Hogg N, Kalyanaraman B. Nitric oxide and lipid peroxidation. Biochim Biophys Acta. 1999;1411:378-384.
82. O'Donnell VB, Eiserich JP, Chumley PH, et al. Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem Res Toxicol. 1999;12:83-92.
83. Peng HB, Libby P, Liao JK. Induction and stabilization of I-κBα by nitric oxide mediates inhibition of NF-κB. J Biol Chem. 1995;270: 14214-14219.
84. Martin LD, Krunkosky TM, Dye JA, et al. The role of reactive oxygen and nitrogen species in the response of airway epithelium to particulates. Environ Health Perspect. 1997;105(suppl 5):1301-1307.
85. Wright DT, Fischer BM, Li CM, et al. Oxidant stress stimulates mucin secretion and PLC in airway epithelium via a nitric oxide-dependent mechanism. Am J Physiol. 1996;271:L854-L861.
86. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271: C1424-C1437.
87. Grisham MB, Jourd'Heuil D, Wink DA. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol. 1999;276:G315-G321.
88. Patel RP, McAndrew J, Sellak H, et al. Biological aspects of reactive nitrogen species. Biochim Biophys Acta. 1999;1411:385-400.
89. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol. 1995;268:L699-L722.
90. Burney S, Caulfield JL, Niles JC, et al. The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutation Res. 1999; 424:37-49.
91. Xia Y, Tsai A-L, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase. J Biol Chem. 1998;273:25804-25808.
92. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 1998;356:1-11.
93. van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE. Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenominae or pathobiological mechanism of disease. Am J Respir Crit Care Med. 1999;1999:160:1-9.
94. Haddad IY, Pataki G, Hu P, et al. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest. 1994;94:2407-2413.
95. Saleh D, Ernst P, Lim S, et al. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. Faseb J. 1998;12:929-937.
96. Eiserich JP, Cross CE, Jones AD, et al. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid: a novel mechanism for nitric oxide-mediated protein modification. J Biol Chem. 1996;271:19199-19208.
97. Eiserich JP, Hristova M, Cross CE, et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 1998;391:393-397.
98. van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite: a potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem. 1997;272:7617-7625.
99. Abu-Soud HM, Hazen SL. Nitric oxide modulates the catalytic activity of myeloperoxidase. J Biol Chem. 2000;275:5425-5430.
100. Goodwin DC, Landino LM, Marnett LJ. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis. FASEB J. 1999;13:1121-1136.
101. O'Donnell VB, Taylor KB, Parthasarathy S, et al. 15-Lipoxygenase catalytically consumes nitric oxide and impairs activation of guanylate cyclase. J Biol Chem. 1999;274:20083-20091.
102. Hausladen A, Stamler JS. Nitrosative stress. Meth Enzymol. 1999; 300:389-395.
103. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 1994;78:931-936.
104. Gaston B. Nitric oxide and thiol groups. Biochim Biophys Acta. 1999;1411:323-333.
105. van der Vliet A, 't Hoen PAC, Wong PSY, et al. Formation of S-nitrosothiols via direct nucleophilic nitrosation of thiols by peroxynitrite with elimination of hydrogen peroxide. J Biol Chem. 1998;273:30255-30262.
106. Salvemini D. Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci. 1997;53:576-82.
107. Watkins DN, Garlepp MJ, Thompson PJ. Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide. Br J Pharmacol. 1997;121:1482-1488.
108. Habib A, Bernard C, Lebret M, et al. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J Immunol. 1997;158:3845-3851.
109. Cifuentes J, Ruizoronoz J, Myles C, et al. Interaction of surfactant mixtures with reactive oxygen and nitrogen species. J Appl Physiol. 1995;78:1800-1805.
110. Britigan BE, Edeker BL. Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation. J Clin Invest. 1991;88:1092-1102.
111. Miller RA, Rasmussen GT, Cox CD, Britigan BE. Protease cleavage of iron-transferrin augments pyocyanin-mediated endothelial cell injury via promotion of hydroxyl radical formation. Infect Immun. 1996;64:182-188.
112. Okamoto T, Akaike T, Nagano T, et al. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch Biochem Biophys. 1997;342:261-274.
113. Evans MD, Pryor WA. Cigarette smoking, emphysema, and damage to alpha(1)-proteinase inhibitor. Am J Physiol. 1994;266: L593-L611.
114. Stricklin GP, Hoidal JR. Oxidant-mediated inactivation of TIMP. Matrix Suppl. 1992;1:325.
115. Basbaum C, Lemjabbar H, Longphre M, et al. Control of mucin transcription by diverse injury-induced signaling pathways. Am J Respir Crit Care Med. 1999;160:S44-S48.
116. Jobin C, Sartor RB. The IκB/NFκB system: a key determinant of mucosal inflammation and protection. Am J Physiol. 2000;278: C451-C462.
117. Phelps DT, Ferro TJ, Higgins PJ, et al. TNF-α induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol. 1995;269:L551-L559.
118. Rochelle LG, Fischer BM, Adler KB. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Rad Biol Med. 1998;24:863-868.
119. Allegra L, Moavero NE, Rampoldi C. Ozone-induced impairment of mucociliary transport and its prevention with N-acetylcysteine. Am J Med. 1991;91(suppl C3):67S-71S.
120. Adler V, Yin Z, Tew KD, Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene. 1999;18: 6104-6111.
121. 2-terminal kinases. J Biol Chem. 1996;271:15703-15707.
122. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Ann Rev Immunol. 1997;15:351-369.
123. Schenk PW, Snaar-Jagalska BE. Signal perception and transduction: the role of protein kinases. Biochim Biophys Acta. 1999;1449:1-24.
124. Sen CK. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol. 1998;55:1747-1758.
125. Huang LE, Zhang H, Bae SW, Liu AYC. Thiol reducing reagents inhibit the heat shock response: involvement of a redox mechanism in the heat shock signal transduction pathway. J Biol Chem. 1994;269:30718-30725.
126. Huot J, Houle F, Spitz DR, Landry J. HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res. 1995;56:273-279.
127. Lee PJ, Alam J, Wiegand GW, Choi AMK. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci USA. 1996;93:10393-10398.
128. Wong HR, Wispé JR. The stress response and the lung. Am J Physiol. 1997;273:L1-L9.
129. Bishop A, Marquis JC, Cashman NR, Demple B. Adaptive resistance to nitric oxide in motor neurons. Free Rad Biol Med. 1999; 26:978-86.
130. Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol. 1996;15:9-19.
131. Wong HR, Ryan M, Wispé JR. Stress response decreases NF-κB nuclear translocation and increases I-κBα expression in A549 cells. J Clin Invest. 1997;99:2423-2428.
132. Lush CW, Cepinskas G, Kvietys PR. LPS tolerance in human endothelial cells: reduced PMN adhesion, E-selectin expression, and NF-κB mobilization. Am J Physiol. 2000;278: H853-H861.
133. 2. J Biol Chem. 1996;271:4138-4142.
134. Puddicombe SM, Davies DE. The role of MAP kinases in intracellular signal transduction in bronchial epithelium. Clin Exp Allergy. 2000, 30:7-11.
135. Janssen YM, Matalon S, Mossman BT. Differential induction of c-fos, c-jun, and apoptosis in lung epithelial cells exposed to ROS or RNS. Am J Physiol. 1997;273:L789-L796.
136. 2 redox stress. Am J Respir Cell Mol Biol. 1998;19:786-798.
137. van der Vliet A, Hristova M, Cross CE, et al. Peroxynitrite induces covalent dimerization of EGF receptors. Possible involvement of intermolecular dityrosine crosslinking. J Biol Chem. 1998;273: 31860-31866.
138. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol. 1998; 10:248-253.
139. slund F, Beckwith J. Bridge over troubled waters: sensing stress by disulfide bond formation. Cell. 1999;96:751-753.
140. Lander HM, Hajjar DP, Hempstead BL, et al. A molecular redox switch on p21. J Biol Chem. 1997;272:4323-4326.
141. Tian L, Shi MM, Forman HJ. Increased transcription of the regulatory subunit of gamma-glutamylcysteine synthetase in rat lung epithelial L2 cells exposed to oxidative stress or glutathione depletion. Arch Biochem Biophys. 1997;342:126-133.
142. Kang SW, Chae HZ, Seo MS, et al. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J Biol Chem. 1998; 273:6297-6302.
143. Tamura T, Stadtman TC. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci USA. 1996;93:1006-1011.
144. 2. Am J Physiol. 1997;273:L1029-L1035.
145. Abate C, Patel L, Rauscher FJ III, Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science. 1990;249: 1157-1161.
146. Lando D, Pongratz I, Poellinger L, Whitelaw ML. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1α and the HIF-like Factor. J Biol Chem. 2000; 275:4618-4627.
147. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 1996;274:782-784.
148. Van Antwerp DJ, Martin SJ, Kafri T, et al. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 1996;274:787-789.
149. Li Y, Zhang W, Mantrell LL, et al. Nuclear factor-kB is activated by hyperoxia but does not protect from cell death. J Biol Chem. 1997; 272:20646-20649.
150. Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene. 1999;18:7719-7730.
151. Gruenert DC, Finkbeiner WE, Widdicombe JH. Culture and transformation of human airway epithelial cells. Am J Physiol. 1995;268:L347-L360.
152. Wu R. Growth and differentiation potential of tracheobronchial epithelial cells. In: McDonald JA, ed. Lung Growth and Development. New York: Marcel Dekker; 1997:211-241.
153. Oberley TD, Schultz JL, Li N, Oberley LW. Antioxidant enzyme levels as a function of growth state in cell culture. Free Rad Biol Med. 1995;19:53-65.
154. Paquette NC, Zhang LY, Ellis WA, et al. Vitamin A deficiency enhances ozone-induced lung injury. Am J Physiol. 1996;14:L475-L482.
155. Zimmerman GA, Prescott SM, McIntyre TM. Oxidatively fragmented phospholipids as inflammatory mediators: the dark side of polyunsaturated lipids. J Nutr. 1995;125:S1661-S1665.
156. Smith LL, Johnson BH. Biological activities of oxysterols. Free Rad Biol Med. 1989;7:285-332.
157. Andersson M, Grankvist K. Ascorbate-induced free radical toxicity to isolated islet cells. Int J Biochem Cell Biol. 1995;27:493-498.
158. Sparrow CP, Olszewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J Lipid Res. 1993;34:1219-1228.
159. Barnes PJ. Reactive oxygen species and airway inflammation. Free Rad Biol Med. 1990;9:235-243.
160. Kelly FJ, Mudway I, Blomberg A, et al. Altered lung antioxidant status in patients with mild asthma. Lancet. 1999;354:482-483.
161. Montuschi P, Corradi M, Ciabattoni G, et al. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med. 1999;160:216-220.
162. Bast A, Haenen GR, Doelman CJ. Oxidants and antioxidants: state of the art. Am J Med. 1991;91:2S-13S.
163. Sadeghi-Hashjin G, Folkerts G, Henricks PA, et al. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med. 1996;153:1697-1701.
164. Kaminsky DA, Mitchell J, Carroll N, et al. Nitrotyrosine formation in the airways and lung parenchyma of patients with asthma. J Allergy Clin Immunol. 1999;104:747-754.
165. 2-adrenergic receptor palmitoylation and signaling. J Biol Chem. 1999; 274:26337-26343.
166. Foreman RC, Mercer PF, Kroegel C, Warner JA. Role of the eosinophil in protein oxidation in asthma: possible effects on proteinase/antiproteinase balance. Int Arch Allergy Immunol. 1999;118: 183-186.
167. Wu W, Chen Y, d'Avignon A, Hazen SL. 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry. 1999;38:3538-3548.
168. Horvàth I, Donnelly LE, Kiss A, et al. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax. 1998;53:668-672.
169. Sanders SP. Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic? Am J Respir Cell Mol Biol. 1999;21:147-149.
170. Greene LS. Asthma, oxidant stress, and diet. Nutrition. 1999;15: 899-907.
171. Soutar A, Seaton A, Brown K. Bronchial reactivity and dietary antioxidants. Thorax. 1997;52:166-170.
172. Louie S, Halliwell B, Cross CE. Adult respiratory distress syndrome: a radical perspective. Adv Pharmacol. 1997;38:457-490.
173. Carpenter CT, Price PV, Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest. 1998;114:1653-1659.
174. Lamb NJ, Gutteridge JMC, Baker C, et al. Oxidative damge to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med. 1999; 27:1738-1744.
175. Matthay MA, Geiser T, Matalon S, Ischiropoulos H. Oxidant-mediated lung injury in the acute respiratory distress syndrome. Crit Care Med. 1999;27:2028-2030.
176. Pison U, Seeger W, Buchhorn R, et al. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Resp Dis. 1989;140:1033-1039.
177. Michael JR, Barton RG, Saffle JR, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med. 1998;157:1372-1380.
178. Matalon S, DeMarco V, Haddad IY, et al. Inhaled nitric oxide injures the pulmonary surfactant system of lambs in vivo. Am J Physiol. 1996;270:L273-L280.
179. 2α isoprostane in cystic fibrosis. Lipids. 1999;34:551-556.
180. Paredi P, Shah PL, Montuschi P, et al. Increased carbon monoxide in exhaled air of patients with cystic fibrosis. Thorax. 1999;54:917-920.
181. van der Vliet A, Eiserich JP, Marelich GP, et al. Oxidative stress in cystic fibrosis: does it occur and does it matter? Adv Pharmacol. 1997;38:491-513.
182. Worlitzsch D, Herberth G, Ulrich M, During G. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J. 1998;11:377-383.
183. Brown RK, Wyatt H, Price JF, Kelly FJ. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J. 1996; 9:334-339.
184. Meyer KC, Zimmerman J. Neutrophil mediators, pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med. 1993;121:654-661.
185. Koller DY, Urbanek R, Gotz M. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am J Respir Crit Care Med. 1995;152:629-633.
186. Witko-Sarsat V, Allen RC, Paulais M, et al. Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J Immunol. 1996;157:2728-2735.
187. Grasemann H, Ratjen F. Cystic fibrosis lung disease: the role of nitric oxide. Ped Pulmonol. 1999;28:442-448.
188. Linnane SJ, Keatings VM, Costello CM, et al. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Resp Crit Care Med. 1998;158:207-212.
189. Kelley TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest. 1998;102:1200-1207.
190. Meng QH, Springall DR, Bishop AE, et al. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol. 1998;184:323-331.
191. Steagall WK, Elmer HL, Brady KG, Kelley TJ. Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression. Am J Respir Mol Cell Biol. 2000;22:45-50.
192. Smith AW, Green J, Eden CE, Watson ML. Nitric oxide-induced potentiation of the killing of Burkholderia cepacia by reactive oxygen species: implications for cystic fibrosis. J Med Microbiol. 1999;48:419-423.
193. Senior RM, Shapiro SD. Chronic obstructive pulmonary disease: epidemiology, pathophysiology and pathogenesis. In: Fishman's Pulmonary Disease and Disorders. 3rd ed. Fishmon, AP: Editor. New York: McGraw-Hill; 1997.
194. MacNee W, Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:S58-S65.
195. Sekido Y, Fong KM, Minna JD. Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta. 1998;1378:F21-F59.
196. Helbock HJ, Beckman KB, Shigenaga MK, et al. DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc Natl Acad Sci USA. 1998; 95:288-293.
197. Marnett LJ. Oxyradicals, and DNA damage. Carcinogenesis. 2000; 21:361-370.
198. Ames BN. Micronutrients prevent cancer and delay aging. Toxicol Lett. 1998:102/103:5-18.
199. Collins AR. Oxidative DNA damage, antioxidants, and cancer. BioAssays. 1999;21:238-246.
200. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzyme of cancer chemoprotection and drug resistance. Crit Rev Bioehem Mol Biol. 1995;30:445-600.
201. Souici A-C, Mirkovitch J, Hausel P, et al. Transition mutation in codon 248 of the p53 tumor suppressor gene by reactive oxygen species and a nitric oxide-releasing compound. Carcinogenesis. 2000;21: 281-287.
202. Griendling KK, Harrison DG. Dual role of reactive oxygen species in vascular growth. Circ Res. 1999;85:562-563.
203. Jadeski LC, Hum KO, Chakraborty C, Lala PK. Nitric oxide promotes murine mammary tumor growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer. 2000;86:30-39.
204. Cooper DA, Eldridge AL, Peters JC. Dietary carotenoids and lung cancer: a review of recent research. Nutr Rev. 1999;57:133-145.
205. Pialva SAR, Russell RM. B-Carotene and other carotenoids as antioxidants. J Am Coll Nutr. 1999;18:426-433.
206. Crystal RG. Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. Am J Med. 1991;91:39S-44S.
207. Cross CE, Traber MG, Eiserich JP, van der Vliet A. Micronutrient antioxidants and smoking. Br Med Bull. 1999;55:691-704.
208. McCall MR, Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Rad Biol Med. 1999;26:1034-1053.
209. Baz MA, Tapson VF, Roggli VL, et al. Glutathione depletion in epithelial lining fluid of lung allograft patients. Am J Respir Crit Care Med. 1996;153:742-746.
210. Cantin AM, Hubbard RC, Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Resp Dis. 1989;139:370-372.
211. Roum JH, Buhl R, McElvaney NG, et al. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol. 1993;75:2419-2424.
212. Borok Z, Buhl R, Grimes GJ, et al. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet. 1991;338:215-216.
213. Roum JH, Borok Z, McElvaney NG, et al. Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. J Appl Physiol. 1999;87:438-443.
214. Marrades RM, Roca J, Barbera J, et al. Nebulized glutathione in-duces bronchoconstriction in patients with mild asthma. Am J Respir Crit Care Med. 1997;156:425-430.
215. Bridgeman MME, Marsden M, Macnee W, et al. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. Thorax. 1991;46:39-42.
216. Steinberg FM, Chait A. Antioxidant vitamin supplementation and lipid peroxidation in smokers. Am J Clin Nutr. 1998;68:319-327.
217. Hatch GE. Asthma, inhaled oxidants, and dietary antioxidants. Am J Clin Nutr. 1995;61(suppl):625S-630S.
218. Barnes PJ. Novel approaches and targets for treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 160:572-579.
219. Han J, Ulevitch RJ. Emerging targets for antiinflammatory therapy. Nature Cell Biol. 1999;1:E39-E40.
220. Ono K, Han J. The p38 signal transduction pathway activation and function. Cell Signal. 2000;12: 1-13.
221. Haunstetter A, Izumo S. Toward antiapoptosis as a new treatment modality. Circ Res. 2000;86: 371-376.
222. Benzing A, Brautigam P, Geiger K, et al. Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury. Anesthesiology. 1995;83:1153-1161.
223. Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med. 2000; 342:469-474.
224. Crystal RG. Gene therapy strategies for pulmonary disease. Am J Med. 1992;92:44S-52S.
225. Ennist DL. Gene therapy for lung disease. Trends Pharmacol Sci. 1999;20:260-266.
226. Boucher RC. Status of gene therapy for cystic fibrosis lung disease. J Clin Invest. 1999;103:441-445.
227. Griesenbach U, Scheid P, Hillery de Martin R, et al. Anti-inflammatory gene therapy directed at the airway epithelium. Gene Ther. 2000;7:306-313.
228. Morcillo EJ, Estrela J, Cortijo J. Oxidative stress and pulmonary inflammation: pharmacological intervention with antioxidants. Pharmacol Res. 1999;40:393-404.